About Santa Ana Bio
Santa Ana Bio is a private company based in Alameda, California, incorporated in 2020 in Delaware. It has reported $63,338,298 raised in three offerings on Form D since June 2021. Its chief executive is Peter Emtage.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 16, 2024 | Jun 17, 2024 | $19,999,998of $125.0M target | 10 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Feb 14, 2023 | Feb 28, 2023 | $35,313,642of $70.3M target | 5 | $7.0M | EquityRule 506(b) | Form D ↗ |
| May 17, 2021 | Jun 1, 2021 | $8,024,658of $42.0M target | 1 | $8.0M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $63,338,298 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Santa Ana Bio's Form D filed Jun 17, 2024.
MD
Mittie Doyle
Director
PE
Peter Emtage
Chief Executive Officer and director
JD
Jerel Davis
Director
SF
Shinichiro Fuse
Director
BS
Brendan Bulik-Sullivan
Director
CB
Christine Borowski
Director
MB
Marcelo Bigalo
Director
Earlier filings also listed Thomas Woiwode (director, last listed Feb 2023).